about
Structural insights into calcium-bound S100P and the V domain of the RAGE complexStructural insights into the interaction of human S100B and basic fibroblast growth factor (FGF2): Effects on FGFR1 receptor signalingBlocking the interaction between S100A9 and RAGE V domain using CHAPS molecule: A novel route to drug development against cell proliferationInteraction between S100P and the anti-allergy drug cromolynTargeting the EGFR/PCNA signaling suppresses tumor growth of triple-negative breast cancer cells with cell-penetrating PCNA peptidesAmlexanox Blocks the Interaction between S100A4 and Epidermal Growth Factor and Inhibits Cell ProliferationBlocking the Interactions between Calcium-Bound S100A12 Protein and the V Domain of RAGE Using TranilastTranilast Blocks the Interaction between the Protein S100A11 and Receptor for Advanced Glycation End Products (RAGE) V Domain and Inhibits Cell ProliferationALA-PDT results in phenotypic changes and decreased cellular invasion in surviving cancer cells.Development of a highly sensitive glycan microarray for quantifying AFP-L3 for early prediction of hepatitis B virus-related hepatocellular carcinomaEGFR modulates DNA synthesis and repair through Tyr phosphorylation of histone H4.Cancer-associated carbohydrate antigens as potential biomarkers for hepatocellular carcinoma.Chloride intracellular channel 4 involves in the reduced invasiveness of cancer cells treated by photodynamic therapy.YC-1 inhibits proliferation of breast cancer cells by down-regulating EZH2 expression via activation of c-Cbl and ERKDownregulation of DAB2IP promotes mesenchymal-to-neuroepithelial transition and neuronal differentiation of human mesenchymal stem cells.Suramin blocks interaction between human FGF1 and FGFR2 D2 domain and reduces downstream signaling activity.Nuclear EGFR suppresses ribonuclease activity of polynucleotide phosphorylase through DNAPK-mediated phosphorylation at serine 776.Targeting EMP3 suppresses proliferation and invasion of hepatocellular carcinoma cells through inactivation of PI3K/Akt pathwaySmurf2-mediated degradation of EZH2 enhances neuron differentiation and improves functional recovery after ischaemic strokeThe potential therapeutic applications of olfactory ensheathing cells in regenerative medicine.The potential roles of EZH2 in regenerative medicine.Inhibition of JNK by pi class of glutathione S-transferase through PKA/CREB pathway is associated with carnosic acid protection against 6-hydroxydopamine-induced apoptosis.Pentamidine blocks the interaction between mutant S100A5 and RAGE V domain and inhibits the RAGE signaling pathway.The newly synthesized 2-arylnaphthyridin-4-one, CSC-3436, induces apoptosis of non-small cell lung cancer cells by inhibiting tubulin dynamics and activating CDK1.Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2-induced Globo H expression.EZH2 in Cancer Progression and Potential Application in Cancer Therapy: A Friend or Foe?Alpha-mangostin induces apoptosis through activation of reactive oxygen species and ASK1/p38 signaling pathway in cervical cancer cells.Effect of chitosan on hepatic drug-metabolizing enzymes and oxidative stress in rats fed low- and high-fat diets.Restoration of p53 tumor suppressor pathway in human cervical carcinoma cells by sodium arsenite.Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis.S100B as an antagonist to block the interaction between S100A1 and the RAGE V domain.Association of viral hepatitis and bipolar disorder: a nationwide population-based study.HBV infection increases the risk of macular degeneration: the roles of HBx-mediated sensitization of retinal pigment epithelial cells to UV and blue light irradiationEpigenetic activation of human kallikrein 13 enhances malignancy of lung adenocarcinoma by promoting N-cadherin expression and laminin degradationApplication of a commercial single-port device for robotic single-incision distal pancreatectomy: initial experience
P50
Q21131976-61ABF3C1-D7E8-4715-953B-CD87994D9521Q27686787-670F95E8-AE1E-4E92-BB9D-90BBED3BDD72Q27727691-C773961B-3F00-4A8A-95A6-339F84BF507AQ28252686-EF349782-C099-49B5-B547-612E5D35CF94Q28486075-5AFD3B7F-4A65-4F84-A559-133D8688051AQ28553734-4D54F8FD-255E-4F4C-8ACD-70B768EB1D9AQ28553904-E302DC74-5D62-4B9D-BD60-B6835BF03B88Q31102154-23265FC5-B737-40EF-8613-F0B413F9A52CQ33427060-5F97155B-8E7F-4485-9995-C27EFD4016BAQ33753952-B8FE19EB-BB75-43EA-9DEB-31F3C7369D21Q34109344-3EBE1988-1390-4C4C-BD2C-6AE2CA1C4674Q34341560-10FC7A40-56B2-4F73-BB9C-A4D95D862779Q34549203-F5CA6828-FC0C-421C-92DA-8D04AEE31DEDQ34571374-5F7BF7A7-3C7A-4672-A21D-1EDF95F9F709Q35000947-E1B54317-906D-4DC4-847A-7F9D0D56D8F3Q36069722-B08E8DEF-0E08-4E46-9323-639DE68FD534Q36225686-8150CD09-EB05-4CFA-AB79-AA2D6FEF8D14Q36544237-480541CE-167B-4D64-9443-EF8C8D381940Q36771332-D51786EB-699A-4144-B837-D0772E62106DQ38210873-EEFFB9DA-0AF5-420A-B37F-48111B2FE289Q38342509-FD87E739-57EB-4321-88BF-14420B2BFB26Q38712404-7208D0B3-D99D-48CC-9091-D68337FF8AC5Q38764726-A87BFF17-8A59-489B-9AC8-101BA64D82EAQ38878480-BACBC692-7AED-4C7C-A2F0-4B5DC7E12136Q39079672-F5680B46-9D91-4C1D-B7F4-B0AADCA14DA3Q39340502-B2649EDD-8314-4AED-B38D-327B5074EF2AQ41471104-3AAD0769-6389-4941-B913-44518AFB447CQ43120034-C3DD38D0-04D2-486E-B763-62A399E2930DQ44020844-F3F6A20D-BF66-4CAC-A51B-F8EE7A8A9B19Q49601734-412E58EC-BA7C-4EC9-BCA7-A363DF1DC0F1Q50000872-98EEE8F4-DA49-48FE-AA2F-5DC365727506Q55443448-9AA48DC0-A24A-4E33-87A3-F105BD6D5B91Q58791551-8B1BE134-A83E-426D-B3BD-F5BE575F1D0FQ84148673-0AC366DE-33D9-4CAE-B0FD-361C96EACF45Q87998035-A1643114-9178-45F1-B55B-3E101D91401F
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
研究者
@zh
name
Ruey-Hwang Chou
@ast
Ruey-Hwang Chou
@en
Ruey-Hwang Chou
@es
Ruey-Hwang Chou
@nl
type
label
Ruey-Hwang Chou
@ast
Ruey-Hwang Chou
@en
Ruey-Hwang Chou
@es
Ruey-Hwang Chou
@nl
prefLabel
Ruey-Hwang Chou
@ast
Ruey-Hwang Chou
@en
Ruey-Hwang Chou
@es
Ruey-Hwang Chou
@nl
P31
P496
0000-0002-2297-2180